Bionano Genomics is a global genomics company focused on elevating the health and wellness of all people. Co. provides optical genome mapping, or OGM, for genome analysis and provide a suite of genome analysis solutions designed to enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. Co. provides OGM and software solutions for applications across applied, translational and clinical research and it provides diagnostic services to physicians focusing in medical management for individuals with genetic conditions such as pediatric neurodevelopmental disorders, including autism spectrum disorders. Co. market and sells the Saphyr® system. The BNGO average annual return since 2018 is shown above.
The Average Annual Return on the BNGO average annual return since 2018 page and across the coverage universe of our site,
is a measure of the annualized return over the past ten years (or specified start date) for a given investment
(up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement
period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window
to capture long-term trends.
Thus, researching Average Annual Returns is good practice for investors — whether BNGO average annual return since 2018 or other benchmarks/peers
— and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is
more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors
by performing the BNGO average annual return calculation with any dividends reinvested as applicable (on ex-dates).
|
Free BNGO Email Alerts:
Video: Don't Forget Dividends in Average Annual Return!
